Audrey Zilliox

Director Cmc Leader, Medicine Development & Industrialisation @GSK

Stevenage, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2023 — Present

Director Cmc Leader, Medicine Development & Industrialisation @GSK

View department →

Leads the definition and implementation of Chemistry, Manufacturing & Controls (CMC) strategy for late phase medicines. Leads a cross-functional CMC matrix team which develops the drug substance (API), formulated product and analytical methods, establish clinical supply chain, ensure technology transfer to commercial manufacture and support regulatory submissions, for new medicines from Ph2 to Launch.

EDUCATION

2000 — 2003

Université Paris Sud (Paris XI)

PhD, Organic Chemistry

1997 — 2000

Chimie ParisTech - PSL

Master Degree - Ingenieur

2003 — 2004

RWTH Aachen University

Post-doctoral research associate, Organic Chemistry

ABOUT AUDREY ZILLIOX

Director, CMC Leader, Medicine Development & Industrialisation

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Audrey Zilliox — Director Cmc Leader, Medicine Development & Industrialisation at GSK in Stevenage, GB | Unifers